nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—Pallor—Teniposide—lymphatic system cancer	0.0352	0.0352	CcSEcCtD
Pseudoephedrine—Cerebral haemorrhage—Carmustine—lymphatic system cancer	0.0297	0.0297	CcSEcCtD
Pseudoephedrine—Cerebral haemorrhage—Vincristine—lymphatic system cancer	0.0283	0.0283	CcSEcCtD
Pseudoephedrine—Paranoia—Carmustine—lymphatic system cancer	0.0241	0.0241	CcSEcCtD
Pseudoephedrine—Angina pectoris—Fludarabine—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Pseudoephedrine—Sweating—Teniposide—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Pseudoephedrine—Vertigo—Mechlorethamine—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Pseudoephedrine—Dysuria—Fludarabine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Pseudoephedrine—Anorexia—Mechlorethamine—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Pseudoephedrine—Arrhythmia—Teniposide—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Pseudoephedrine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Pseudoephedrine—Agitation—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Pseudoephedrine—Arrhythmia—Fludarabine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Pseudoephedrine—Hypertension—Teniposide—lymphatic system cancer	0.011	0.011	CcSEcCtD
Pseudoephedrine—Chest pain—Teniposide—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Pseudoephedrine—Urinary retention—Vincristine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Pseudoephedrine—Confusional state—Teniposide—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Pseudoephedrine—Agitation—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Pseudoephedrine—Tachycardia—Teniposide—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Pseudoephedrine—Anorexia—Teniposide—lymphatic system cancer	0.00993	0.00993	CcSEcCtD
Pseudoephedrine—Dyspnoea—Teniposide—lymphatic system cancer	0.00929	0.00929	CcSEcCtD
Pseudoephedrine—Confusional state—Fludarabine—lymphatic system cancer	0.00923	0.00923	CcSEcCtD
Pseudoephedrine—Dysuria—Vincristine—lymphatic system cancer	0.0092	0.0092	CcSEcCtD
Pseudoephedrine—Decreased appetite—Teniposide—lymphatic system cancer	0.00906	0.00906	CcSEcCtD
Pseudoephedrine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00898	0.00898	CcSEcCtD
Pseudoephedrine—Rash—Mechlorethamine—lymphatic system cancer	0.00891	0.00891	CcSEcCtD
Pseudoephedrine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0089	0.0089	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00885	0.00885	CcSEcCtD
Pseudoephedrine—Anorexia—Fludarabine—lymphatic system cancer	0.00873	0.00873	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00858	0.00858	CcSEcCtD
Pseudoephedrine—Sweating—Vincristine—lymphatic system cancer	0.00841	0.00841	CcSEcCtD
Pseudoephedrine—Nausea—Mechlorethamine—lymphatic system cancer	0.00839	0.00839	CcSEcCtD
Pseudoephedrine—Body temperature increased—Teniposide—lymphatic system cancer	0.00823	0.00823	CcSEcCtD
Pseudoephedrine—Hallucination—Carmustine—lymphatic system cancer	0.00821	0.00821	CcSEcCtD
Pseudoephedrine—Sweating—Mitoxantrone—lymphatic system cancer	0.00819	0.00819	CcSEcCtD
Pseudoephedrine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00816	0.00816	CcSEcCtD
Pseudoephedrine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00806	0.00806	CcSEcCtD
Pseudoephedrine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00796	0.00796	CcSEcCtD
Pseudoephedrine—Hallucination—Vincristine—lymphatic system cancer	0.00783	0.00783	CcSEcCtD
Pseudoephedrine—Pain—Fludarabine—lymphatic system cancer	0.00783	0.00783	CcSEcCtD
Pseudoephedrine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00781	0.00781	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00754	0.00754	CcSEcCtD
Pseudoephedrine—Asthenia—Teniposide—lymphatic system cancer	0.00747	0.00747	CcSEcCtD
Pseudoephedrine—Arrhythmia—Carmustine—lymphatic system cancer	0.00737	0.00737	CcSEcCtD
Pseudoephedrine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00724	0.00724	CcSEcCtD
Pseudoephedrine—Chest pain—Bleomycin—lymphatic system cancer	0.007	0.007	CcSEcCtD
Pseudoephedrine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00685	0.00685	CcSEcCtD
Pseudoephedrine—Confusional state—Bleomycin—lymphatic system cancer	0.00677	0.00677	CcSEcCtD
Pseudoephedrine—Tremor—Carmustine—lymphatic system cancer	0.00673	0.00673	CcSEcCtD
Pseudoephedrine—Vomiting—Teniposide—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Pseudoephedrine—Agitation—Carmustine—lymphatic system cancer	0.0066	0.0066	CcSEcCtD
Pseudoephedrine—Asthenia—Fludarabine—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Pseudoephedrine—Rash—Teniposide—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Pseudoephedrine—Dermatitis—Teniposide—lymphatic system cancer	0.00656	0.00656	CcSEcCtD
Pseudoephedrine—Headache—Teniposide—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Pseudoephedrine—Anorexia—Bleomycin—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Pseudoephedrine—Agitation—Vincristine—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Pseudoephedrine—Hypertension—Carmustine—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Pseudoephedrine—Nausea—Teniposide—lymphatic system cancer	0.00619	0.00619	CcSEcCtD
Pseudoephedrine—Vertigo—Vincristine—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Pseudoephedrine—Chest pain—Carmustine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Pseudoephedrine—Anxiety—Carmustine—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Pseudoephedrine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00598	0.00598	CcSEcCtD
Pseudoephedrine—Hypertension—Vincristine—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Pseudoephedrine—Confusional state—Carmustine—lymphatic system cancer	0.00591	0.00591	CcSEcCtD
Pseudoephedrine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Pseudoephedrine—Vomiting—Fludarabine—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Pseudoephedrine—Rash—Fludarabine—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Pseudoephedrine—Dermatitis—Fludarabine—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Pseudoephedrine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00576	0.00576	CcSEcCtD
Pseudoephedrine—Pain—Bleomycin—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Pseudoephedrine—Headache—Fludarabine—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Pseudoephedrine—Tachycardia—Carmustine—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Pseudoephedrine—Chest pain—Mitoxantrone—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Pseudoephedrine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00566	0.00566	CcSEcCtD
Pseudoephedrine—Anorexia—Carmustine—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Pseudoephedrine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Pseudoephedrine—Nausea—Fludarabine—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Pseudoephedrine—Anorexia—Vincristine—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Pseudoephedrine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Pseudoephedrine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Pseudoephedrine—Insomnia—Carmustine—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Pseudoephedrine—Irritability—Methotrexate—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Pseudoephedrine—Dyspnoea—Carmustine—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Pseudoephedrine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Pseudoephedrine—Decreased appetite—Carmustine—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Pseudoephedrine—Insomnia—Vincristine—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Pseudoephedrine—Pain—Carmustine—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Pseudoephedrine—Decreased appetite—Vincristine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Pseudoephedrine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Pseudoephedrine—Asthenia—Bleomycin—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Pseudoephedrine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Pseudoephedrine—Pain—Vincristine—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Pseudoephedrine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Pseudoephedrine—Pain—Mitoxantrone—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Pseudoephedrine—Body temperature increased—Carmustine—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Pseudoephedrine—Dysuria—Methotrexate—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Pseudoephedrine—Body temperature increased—Vincristine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Pseudoephedrine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Pseudoephedrine—Vomiting—Bleomycin—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Pseudoephedrine—Rash—Bleomycin—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Pseudoephedrine—Dermatitis—Bleomycin—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Pseudoephedrine—Asthenia—Carmustine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Pseudoephedrine—Sweating—Methotrexate—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Pseudoephedrine—Asthenia—Vincristine—lymphatic system cancer	0.00401	0.00401	CcSEcCtD
Pseudoephedrine—Nausea—Bleomycin—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Pseudoephedrine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Pseudoephedrine—Dizziness—Carmustine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Pseudoephedrine—Vomiting—Carmustine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Pseudoephedrine—Dizziness—Vincristine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Pseudoephedrine—Rash—Carmustine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Pseudoephedrine—Dermatitis—Carmustine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Pseudoephedrine—Headache—Carmustine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Pseudoephedrine—Vomiting—Vincristine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Pseudoephedrine—Rash—Vincristine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Pseudoephedrine—Dermatitis—Vincristine—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Pseudoephedrine—Headache—Vincristine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Pseudoephedrine—Nausea—Carmustine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Pseudoephedrine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Pseudoephedrine—Rash—Mitoxantrone—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Pseudoephedrine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Pseudoephedrine—Headache—Mitoxantrone—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Pseudoephedrine—Nausea—Vincristine—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Pseudoephedrine—Nausea—Mitoxantrone—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Pseudoephedrine—Vertigo—Methotrexate—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Pseudoephedrine—Chest pain—Methotrexate—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Pseudoephedrine—Confusional state—Methotrexate—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Pseudoephedrine—Anorexia—Methotrexate—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Pseudoephedrine—Insomnia—Methotrexate—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Pseudoephedrine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Pseudoephedrine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Pseudoephedrine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Pseudoephedrine—Pain—Methotrexate—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Pseudoephedrine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Pseudoephedrine—Asthenia—Methotrexate—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Pseudoephedrine—Dizziness—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Pseudoephedrine—Vomiting—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Pseudoephedrine—Rash—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Pseudoephedrine—Dermatitis—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Pseudoephedrine—Headache—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Pseudoephedrine—Nausea—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
